The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice-Reference-Cited by-同舟云学术

The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice

Published:2023-10 Issue: Volume:246 Page:106986
ISSN:0001-706X
Container-title:Acta Tropica
language:en
Short-container-title:Acta Tropica

Author:

Lage Daniela P.,Martins Vívian T.,Vale Danniele L.,Freitas Camila S.^ORCID,Pimenta Breno L.,Moreira Gabriel J.L.,Ramos Fernanda F.,Pereira Isabela A.G.,Bandeira Raquel S.,de Jesus Marcelo M.,Ludolf Fernanda,Tavares Grasiele S.V.,Chávez-Fumagalli Miguel A.,Roatt Bruno M.,Christodoulides Myron^ORCID,Coelho Eduardo A.F.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Infectious Diseases,Parasitology,Insect Science,Veterinary (miscellaneous)

Reference43 articles.

1. Immunotherapy in treatment of leishmaniasis;Akbari;Immunol. Lett.,2021

2. Immune response to Leishmania infection;Awasthi;Indian J. Med. Res.,2004

3. Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis;Borja-Cabrera;Vaccine,2010

4. Leishmaniasis;Burza;Lancet.,2018

5. New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment;Chávez-Fumagalli;Rev. Soc. Bras. Med. Trop.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species;Experimental Parasitology;2024-05

2. Immunotherapy Combining Mimotopes Selected by Phage Display Plus Amphotericin B Is Effective for Treatment Against Visceral Leishmaniasis;Parasite Immunology;2024-05

3. New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasis;Cytokine;2024-05